Med Sci (Paris)
Volume 34, Number 11, Novembre 2018
Nos jeunes pousses ont du talent !
Page(s) 1006 - 1008
Section Partenariat médecine/sciences - Écoles doctorales - Masters
Published online 10 December 2018
  1. Sun Y, Zhou H, Yang Bx. Drug discovery for polycystic kidney disease. Acta Pharmacol 2011; 32 : 805–16. [Google Scholar]
  2. Willey CJ Blais JD Hall AK et al. Prevalence of autosomal dominant polycystic disease in the European Union. Nephrol Dial Transplant 2016 ; 32 : 1356–1363. [Google Scholar]
  3. Torres VE Harris PC Autosomal dominant polycstic disease: The last three years. Kidney Int 2009 ; 76 : 149–168. [CrossRef] [PubMed] [Google Scholar]
  4. Mangoo-Karim R Uchic ME Grant M et al. Renal epithelial fluid secretion and cyst growth: The role of cyclic AMP. FASEB J 1989 ; 3 : 2629–2632. [CrossRef] [PubMed] [Google Scholar]
  5. Torres VE Chapman AB Devuyst O et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 2012 ; 367 : 2407–2418. [Google Scholar]
  6. Gattone VH Wang X Harris PC Torres VE Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 2003 ; 9 : 1323–1326. [CrossRef] [PubMed] [Google Scholar]
  7. King GF Venoms to drugs, drug discovery 2015 ; London Royal society of Chemistry P001–P320. [CrossRef] [Google Scholar]
  8. Rouget C Quinton L Maïga A et al. Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2-adrenoceptors. Br J Pharmacol 2010 ; 161 : 1361–1374. [CrossRef] [PubMed] [Google Scholar]
  9. Ciolek J Reinfrank H Quinton L et al. Green mamba peptide targets type-2 vasopressin. Proc Natl Acad Sci USA 2017 ; 114 : 7154–7159. [CrossRef] [Google Scholar]
  10. Gasparini S Danse JM Lecoq A et al. Delineation of the functional site of α-dendrotoxin: The functional topographies of dendrotoxins are different but share a conserved core with those of other Kv1 potassium channel-blocking toxins. J Biol Chem 1998 ; 273 : 25393–25403. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.